Jefferies Group LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 228 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,003,167
+35.9%
150,100
+33.4%
0.03%
+11.5%
Q1 2021$2,945,250
+4.1%
112,5000.0%0.03%
+18.2%
Q4 2020$2,830,500
-40.9%
112,500
-35.4%
0.02%
-40.5%
Q3 2019$4,788,000
+2.7%
174,223
+23.7%
0.04%
+8.8%
Q2 2019$4,662,000
+179.3%
140,893
+195.7%
0.03%
+142.9%
Q1 2019$1,669,000
+5.8%
47,641
+52.0%
0.01%
+40.0%
Q3 2018$1,578,000
+447.9%
31,340
+552.2%
0.01%
+400.0%
Q2 2018$288,000
-25.2%
4,805
-50.2%
0.00%0.0%
Q4 2017$385,000
-84.5%
9,652
-83.2%
0.00%
-87.5%
Q2 2017$2,479,000
+12.7%
57,500
-18.2%
0.02%0.0%
Q1 2017$2,200,000
+73233.3%
70,271
+43277.2%
0.02%
Q2 2015$3,000
-99.4%
162
-99.6%
0.00%
-100.0%
Q1 2015$544,000
-87.7%
44,990
-91.2%
0.00%
-90.0%
Q3 2014$4,419,000
+61.1%
508,536
+103.0%
0.03%
+30.4%
Q2 2014$2,743,000
+2439.8%
250,472
+1603.9%
0.02%
+2200.0%
Q3 2013$108,00014,7000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders